<span item_type="fundamental" item_id="ec77d4f808b2f63dd6fe5042999224d5" counter_id="ST/US/AIMD" env="prod"></span><span item_type="announcement" item_id="648018384274135937" env="prod"></span><p>Revenue: As of FY2026 Q1, the actual value is USD 161.</p><p>EBIT: As of FY2026 Q1, the actual value is USD -2.107 M.</p><p></p><p>Ainos, Inc. reported its financial results for the first quarter ended March 31, 2026, indicating a continued transition towards industrial and infrastructure-focused AI Nose deployments <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p><h4>Revenue</h4><p>Revenues for the first quarter of 2026 were $161, a decrease from $106,207 in the first quarter of 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p><h4>Gross Profit (Loss)</h4><p>The company reported a gross loss of -$602 for the first quarter of 2026, compared to a gross profit of $87,974 for the same period in 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Cost of revenues was -$763 in Q1 2026, compared to -$18,233 in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p><h4>Operating Expenses</h4><p>Total operating expenses for the first quarter of 2026 were $2,283,045, a decline of approximately 30% year-over-year from $3,250,845 in the first quarter of 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Research and development expenses were $1,689,860 in Q1 2026, down from $1,724,084 in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Selling, general and administrative expenses decreased to $593,185 in Q1 2026 from $1,526,761 in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p><h4>Loss from Operations</h4><p>Loss from operations was -$2,283,647 for the first quarter of 2026, an improvement from -$3,162,871 in the first quarter of 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p><h4>Non-Operating Expenses, Net</h4><p>Total non-operating expenses, net, were -$176,153 in Q1 2026, compared to -$123,151 in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Interest expense was -$176,876 in Q1 2026, compared to -$180,445 in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Other income, net, was $723 in Q1 2026, compared to $57,294 in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p><h4>Net Loss</h4><p>Net loss before income taxes was -$2,459,800 for the first quarter of 2026, an improvement from -$3,286,022 in the first quarter of 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. The net loss for the first quarter of 2026 was -$2,459,800, compared to -$3,286,022 for the first quarter of 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p><h4>Balance Sheet Highlights (as of March 31, 2026)</h4><p>Cash and cash equivalents increased to $2,841,422 as of March 31, 2026, from $417,353 as of December 31, 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Total current assets were $3,519,615 as of March 31, 2026, up from $1,138,799 as of December 31, 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Total assets amounted to $22,081,583 as of March 31, 2026, compared to $20,871,108 as of December 31, 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Total current liabilities were $6,346,479 as of March 31, 2026, significantly higher than $1,078,683 as of December 31, 2025, partly due to new convertible notes payable and loan payable to related parties <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Total liabilities were $16,389,637 as of March 31, 2026, compared to $13,308,526 as of December 31, 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Total stockholders’ equity was $5,691,946 as of March 31, 2026, down from $7,562,582 as of December 31, 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. The company strengthened its balance sheet and liquidity position through a previously announced NT$90 million (approximately US$2.8 million) financing arrangement <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p><h4>Operational Metrics and Strategic Initiatives</h4><p>Ainos, Inc. continued deployment activities for an approximately three-year, $2.1 million AI Nose commercial arrangement in backend semiconductor manufacturing environments, targeting about 1400 AI Nose systems <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Pilot and validation activities were initiated in selected front-end semiconductor environments <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. The company expanded industrial commercialization initiatives through a distribution partnership for front-end semiconductor opportunities <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. AI Nose deployment expanded into healthcare infrastructure settings, including hospital utility systems, laboratory environments, HVAC-related monitoring, MRI-related environments, and critical infrastructure safety applications <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Development of Smell ID datasets and Smell Language Model capabilities continued through deployment and pilot activities <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. Optimization of AI Nose’s near-threshold sensing and pattern-recognition capabilities is ongoing, supporting earlier identification of environmental anomalies <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p><h4>Outlook</h4><p>Ainos, Inc. anticipates that its current execution priorities will facilitate broader revenue generation opportunities in the second half of 2026 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. The company is focused on execution, deployment readiness, Smell ID dataset expansion, and Smell Language Model development <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>. These efforts support the long-term objective of advancing AI Nose as a scalable Smell AI platform for real-world infrastructure environments <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1014763/000149315226022751/ex99-1.htm"></span>.</p>

Ainos | 8-K: FY2026 Q1 Revenue: USD 161